Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. F/m Emerald Life Sciences Innovation ETF (LFSC) is part of the Life Sciences segment. Both ETFs have the same top 3 sector exposures: and Health Care. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.79% for LFSC. PSCH is down -9.57% year-to-date (YTD) with -$14M in YTD flows. LFSC performs better with -7.57% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of PSCH and LFSC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH LFSC | -4.98%-5.12% | -13.47%-13.36% | -9.57%-7.57% | -4.84%+48.56% | -5.55%n/a | -37.27%n/a |
| Flows | PSCH LFSC | -$12M+$6M | -$15M+$6M | -$14M+$5M | -$33M+$16M | -$168M- | -$230M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH LFSC | +19.05%+22.88% | +23.19%+28.76% | +21.52%n/a | +22.79%n/a |
| Max drawdown | PSCH LFSC | -13.93%-13.77% | -13.93%-19.03% | -23.50%n/a | -47.23%n/a |
| Max drawdown duration | PSCH LFSC | 80d77d | 80d70d | 449dn/a | 1719dn/a |
PSCH | LFSC | |
Last sale 3/12/2026 at 1:30 PM | $39.81 | $33.82 |
| Previous close 03/12/2026 | $41.15 | $35.01 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PSCH | LFSC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PSCH | LFSC | |
|---|---|---|
| Last price | $39.81 | $33.82 |
| 1D performance | -3.26% | -3.41% |
| AuM | $120.40 M | $90.59 M |
| E/R | 0.29% | 0.79% |
PSCH | LFSC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Emerald Group |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | - |
| N° of holdings | 71 | 34 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | October 31, 2024 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
